Uploaded May 2024 | Updated September 2026, 2 hours ago
Lecture by Dr Robert Langer, member of the Molecular Frontiers Scientific Advisory Board, at the Molecular Frontiers Symposium "On Human Origins and the Future of Humanity", at Lund University April 18-19, 2024. The symposium was co-organized with Lund University and the Royal Physiographic Society of Lund.
ABSTRACT:
Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. This early research then led to new drug delivery technologies including nanoparticles and nanotechnology that are now being studied for use treating cancer, other illnesses, and in vaccine delivery (including the Covid-19 vaccine). Approaches for synthesizing new biomaterials are then examined. Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may help in treating various diseases. They also enable the creation of organs and tissues on a chip which may someday reduce animal and human testing.
Lecture by Dr Robert Langer, member of the Molecular Frontiers Scientific Advisory Board, at the Molecular Frontiers Symposium "On Human Origins and the Future of Humanity", at Lund University April 18-19, 2024. The symposium was co-organized with Lund University and the Royal Physiographic Society of Lund.
ABSTRACT:
Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. This early research then led to new drug delivery technologies including nanoparticles and nanotechnology that are now being studied for use treating cancer, other illnesses, and in vaccine delivery (including the Covid-19 vaccine). Approaches for synthesizing new biomaterials are then examined. Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may help in treating various diseases. They also enable the creation of organs and tissues on a chip which may someday reduce animal and human testing.
